Nabras Al-Mahrami | Proteomics | Best Researcher Award

Mr. Nabras Al-Mahrami | Proteomics | Best Researcher Award

Oman College of Health Sciences, Oman

Author Profiles đź“š

Scopus

Orcid

Early Academic Pursuits 🎓

Mr. Nabras Al-Mahrami’s academic journey has been marked by a strong foundation in molecular medicine and bioinformatics. After completing his BSc in Medical Laboratory Science at Oman College of Health Sciences in 2018, he pursued an MSc in Molecular Medicine (Bioinformatics) at the Cyprus Institute of Neurology and Genetics in Cyprus, graduating in 2022. His research project, titled “Bioinformatics approach to related genetic variants with functionality, phenotype, and pathogenicity,” underscores his deep interest in understanding the genetic basis of diseases through bioinformatics techniques. This academic background enabled him to merge laboratory science with computational biology seamlessly.

Professional Endeavors 🧬

Mr. Al-Mahrami has developed a strong professional profile, especially in bioinformatics, through his roles at Oman College of Health Sciences and the National Genetic Center. As a Bioinformatician at the Royal Hospital in Muscat from 2018 to 2024, he played a key role in genomics data analysis, developing pipelines for whole genome sequencing (WGS), whole exome sequencing (WES), and target panel analysis. His work also spanned Genome-Wide Association Studies (GWAS), Gene Set Enrichment Analysis (GSEA), RNA-seq analysis, and proteomics data analysis, demonstrating his broad and diverse expertise in the molecular biology and bioinformatics fields.

Contributions and Research Focus 🔬

Mr. Al-Mahrami’s research has greatly contributed to the field of bioinformatics, particularly in genetic variant analysis, phenotypic predictions, and understanding the pathogenicity of diseases. His use of advanced tools like machine learning, molecular docking, and network interaction analysis in the development of bioinformatics tools has further enhanced the precision of genomic research. His impactful research involves bridging the gap between bioinformatics, molecular genetics, and clinical applications, fostering advancements in precision medicine.

Impact and Influence 🌍

Through his work, Mr. Al-Mahrami has influenced bioinformatics research not only in Oman but globally. His involvement in high-profile conferences, such as the 5th Congress of Reproductive Genetics and the Precision Med Exhibit and Summit 2023, has allowed him to share his insights on cutting-edge genetic technologies and their clinical applications. His academic contributions have positioned him as a key figure in applying bioinformatics approaches to real-world medical challenges.

Academic Cites đź“š

Mr. Al-Mahrami has contributed significantly to academic advancements. His research and presentations have been featured at various scientific conferences and workshops, such as the Gene Set Enrichment Analysis Workshop hosted by the Swiss Bioinformatics Institute. His academic works and insights into genetic technologies are widely cited and discussed in the bioinformatics and medical communities, particularly regarding the potential of AI-driven bioinformatics tools in healthcare.

Technical Skills đź’»

Mr. Al-Mahrami possesses advanced technical skills essential for modern bioinformatics. His proficiency in R (RStudio) and Python programming allows him to handle large datasets and perform complex analyses, while his experience with Linux OS and HPC ensures that his computational work is efficient and scalable. Additionally, his knowledge in CSS and JavaScript aids in the development of user-friendly bioinformatics tools and applications.

Teaching Experience👨‍🏫

In 2024, Mr. Al-Mahrami took on the role of Academic Faculty in Bioinformatics at Oman College of Health Sciences, where he teaches Principles of Bioinformatics, covering both theoretical and practical modules, and Laboratory Management. His ability to impart knowledge to students helps shape the next generation of bioinformaticians, ensuring they are equipped with both theoretical insights and hands-on experience in the field. His passion for education extends beyond the classroom, influencing students to pursue careers in bioinformatics and molecular medicine.

Legacy and Future Contributions 🌟

Looking forward, Mr. Al-Mahrami’s journey is marked by his commitment to expanding bioinformatics research and education in Oman and beyond. His work in genomic data analysis, AI integration, and bioinformatics tools development lays the groundwork for future innovations in personalized medicine. His legacy will likely include contributing to groundbreaking research and training future generations of bioinformaticians, particularly in regions with emerging biomedical research landscapes. With his continued involvement in both academia and research, his influence on the scientific community is poised to grow, fostering a deeper understanding of the genetic basis of diseases and improving patient care globally.

Top Noted Publications đź“–

Exploring advanced genomic and immunoinformatics techniques for identifying drug and vaccine targets against SARS-CoV-2
    • Authors: Syed Luqman Ali, Awais Ali, Waseef Ullah, Abdulaziz Alamri, Elham Mohammed Khatrawi, Gulzira Sagimova, Aigul Almabayeva, Farida Rakhimzhanova, Gulsum Askarova, Fatima Suleimenova et al.
    • Journal: Journal of Genetic Engineering and Biotechnology
    • Year: 2024
In-silico and in-vitro studies to identify potential inhibitors of SARS-CoV-2 spike protein from Omani medicinal plants
    • Authors: Nabras Al-Mahrami, Smitha Sunil Kumaran Nair, Adhra Al Mawali, Raja-Mohamed Beema Shafreen, Saeed Ullah, Sobia Ahsan Halim, Ahmed Al-Harrasi, Nallusamy Sivakumar
    • Journal: Heliyon
    • Year: 2024
Bioinformatics Approach is Unraveling Potential Crosstalk between Cytomegalovirus and Epilepsy
    • Authors: Salim Al Rashdi, Nabras Al-Mahrami
    • Journal: Preprint
    • Year: 2024
PlantMedOman: an online database for Oman’s medicinal plants
    • Authors: Department of Computing and Electronics Engineering, Middle East College, Sultanate of Oman; Smitha Sunil Kumaran Nair; Aqsa Bibi; Nabras Al-Mahrami; Piyusha Mahesh Satam; Alya Al Farsi et al.
    • Journal: Bioinformation
    • Year: 2024

farnaz shokraneh | personalized medicine | Best Researcher Award

Ms. farnaz shokraneh | personalized medicine | Best Researcher Award

Abo Akademi University, Finland

👨‍🎓Professional Profile 

Orcid Profile

👩‍🔬 Summary

Ms. Farnaz Shokraneh is an experienced pharmaceutical professional currently working as a Doctoral Researcher in Pharmaceutical Development and Medical Technology at Ă…bo Akademi University in Turku, Finland. With a solid academic background and extensive practical experience in pharmaceutical quality assurance, regulatory compliance, and research, she brings valuable insights into the development of pharmaceutical products and systems. She is committed to advancing personalized medicine and improving quality control in the pharmaceutical industry.

🎓 Education

Ms. Shokraneh holds a Doctor of Pharmacy degree, equivalent to a Finnish Master’s, from Islamic Azad University, Tehran, Iran (2007-2012). She furthered her academic journey with a Master’s in Pharmaceutical Research from Freie Universität Berlin, Germany (2022-2024). Currently, she is pursuing her doctoral research in Pharmaceutical Development and Medical Technology at Åbo Akademi University, Turku, Finland (2022–present).

đź’Ľ Professional Experience

Ms. Shokraneh has accumulated extensive experience in various roles within the pharmaceutical industry. She is currently serving as a Quality Manager at CurifyLabs Oy in Helsinki, Finland, since September 2022. Previously, she held the position of Quality Assurance Manager at Mofid Pharma under the license of Bayer Pharmaceutical Company (Dec 2020–Dec 2021). Additionally, she has worked at Modava Pharmaceutical under Novartis (Jul 2018–Jul 2020) and ATI Pharmed Pharmaceutical Co under StragenPharma and CHEMO Pharmaceutical licenses (Apr 2013–Jun 2017).

🛠️ Technical Skills

Ms. Shokraneh’s technical expertise encompasses pharmaceutical development, quality assurance, and regulatory compliance. She is proficient in analytical techniques such as HPLC, mass spectrometry, and micro NIR spectrophotometry. Her experience also extends to pharmacovigilance, safety monitoring, and statistical analysis for pharmaceutical applications, making her highly skilled in ensuring the safety, efficacy, and quality of pharmaceutical products.

🧑‍🏫 Teaching Experience

Although Ms. Shokraneh’s current focus is on research and industry roles, her vast knowledge and experience in the pharmaceutical field allow her to effectively mentor teams and share her expertise. She has contributed to the professional development of her colleagues and participated in educational training programs within the pharmaceutical sector.

🔬 Research Interests

Ms. Shokraneh’s primary research interests lie in pharmaceutical development and medical technology, with a particular focus on personalized medicine. She is passionate about improving drug safety and efficacy through innovations in automated pharmacy compounding, quality control, and exploring new methods for drug delivery and patient-specific treatment plans.

 

đź“–Top Noted Publications

Automated Non-Sterile Pharmacy Compounding: A Multi-Site Study in European Hospital and Community Pharmacies with Pediatric Immediate Release Propranolol Hydrochloride Tablets

Authors: Niklas Sandler Topelius, Farnaz Shokraneh, Mahsa Bahman, Julius Lahtinen, Niko Hassinen, Sari Airaksinen, Soumya Verma, Ludmila Hrizanovska, Jana Lass, Urve Paaver et al.

Journal: Pharmaceutics

Year: 2024

A Novel High Performance Liquid Chromatographic Method for Determination of Nystatin in Pharmaceutical Formulations by Box–Behnken Statistical Experiment Design

Authors: Farnaz Shokraneh

Journal: Iranian Journal of Pharmaceutical Research

Year: 2014

Comparative Studies of Cytotoxic Manufacturing Practices in Specialized Cancer Centers Against International Guidelines (ASHP, OSHA, HSE-UK)

Authors: Farnaz Shokraneh

Journal: FIP Congress

Year: 2012

Development and Validation of High-Performance Liquid Chromatography for Determination of Nystatin in Pharmaceutical Formulations

Authors: Farnaz Shokraneh

Journal: Research in Pharmaceutical Science

Year: 2012

A New HPLC Method for Determination of Losartan in Human Plasma and Its Application in Bioequivalence Studies

Authors: Farnaz Shokraneh

Journal: Oriental Journal of Chemistry

Year: 2012

Risks to Health Professionals from Hazardous Drugs in Iran: A Pilot Study of Understanding of Healthcare Team to Occupational Exposure to Cytotoxics

Authors: Farnaz Shokraneh

Journal: EXCLI Journal

Year: 2005